Company profile: Charnwood Molecular
1.1 - Company Overview
Company description
- Provider of medicinal and synthetic chemistry services to the global pharmaceutical, biotechnology and chemical industries, emphasizing regular, open client communication, integrity in business relationships, high-quality yet cost-effective services, and flexibility.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Charnwood Molecular
AnaBios
HQ: United States
Website
- Description: Provider of human-focused contract research services and products for biotech and pharma drug discovery, using ex vivo studies of human donor organs and tissues. Includes ethical human tissue and cell procurement, human primary cells and media, RIN analysis, custom tissue collection, cryopreserved human hepatocytes, and high-quality human heart tissue for cardiovascular preclinical research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AnaBios company profile →
Shedir Pharma
HQ: Italy
Website
- Description: Provider of nutraceuticals, cosmetics, and medical devices, serving specialized operators in the medical and pharmaceutical sectors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Shedir Pharma company profile →
Reaction Biology
HQ: United States
Website
- Description: Provider of assay services and protein production for early-stage drug discovery, including biochemical, biophysical, electrophysiological and cell assays for high throughput screening (HTS); kinase and epigenetic assays; recombinant and custom protein production; 2D/3D cell-based assays; in vivo pharmacology (xenograft, immuno-oncology tumor models); and ADME & safety with in vitro safety screening, cardiac safety assessment, and in vivo PK/PD studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reaction Biology company profile →
Inventiv Health
HQ: United States
Website
- Description: Provider of global clinical and commercial professional services helping biopharmaceutical companies streamline processes and evolve and innovate.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inventiv Health company profile →
Omega Laboratory
HQ: Canada
Website
- Description: Provider of healthcare products and services for the pharmaceutical industry, producing injectable and non-injectable solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Omega Laboratory company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Charnwood Molecular
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Charnwood Molecular
2.2 - Growth funds investing in similar companies to Charnwood Molecular
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Charnwood Molecular
4.2 - Public trading comparable groups for Charnwood Molecular
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →